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INTRODUCTION

INTRODUCTION

The polyamines are low molecular weight organic cations which are widely
distributed in biological systems.

They occur in virtually every animal

and plant tissue in which they have been sought, and in most microorganisms as well.

Levels of polyamines markedly rise in cells

(in¬

cluding tumor cells) during growth, and polyamines have a variety of
well-characterized effects on nucleic acids in vitro.

Recently, a

body of evidence has accumulated implicating these molecules in the
mechanisms of hormone actions on target tissues.

While their true

physiological role remains undefined, polyamines appear to be important
in the regulation of nucleic acid and protein metabolism.

Historical aspects
The polyamines of greatest biological significance are spermi¬
dine and spermine, aminopropyl derivatives of the diamine, putrescine.
In the same letter to the Royal Society in 1677 in which he described
human spermatozoan "animalcules",

Leewenhoek reported observing the grad¬

ual formation of colorless crystals in semen which were probably spermine phosphate.

103

These crystals were rediscovered in 1791 by Vaquelin,

who was apparently unaware of Leewenhoek’s observations, and were studied
in turn by Boettcher, Charcot, Schreiner, and Poehl, each of whom be¬
came affiliated by name with the substance; by the end of the 19th cen¬
tury spermine was known by no less than ten names.24,138,181

poepi

isolated spermine phosphate from testis, prostate, and several other
1

2
organs; he also promoted his "Sperminum Poehl" commercially as a cure
for cholera and other conditions
traces of spermine.) ^^
sociates, and Wrede,

(the material actually contained only

It was not until the work of Rosenheim and as¬

in the 1920's, that the correct structure of sper¬

mine was elucidated and confirmed by synthesis.31>153,198

However, for

the next two decades, scientific attention was focused on the amino acids
and away from these polyamines which were presumed to be mere products of
amino acid catabolism.

The discovery by Herbst and Snell in 1949 of

a polyamine-requiring mutant of Hemophilus parainfluenza again stimur /:

lated interest in the biological role of these compounds.

Improved

quantitative assays and chromatographic separation techniques followed
in the 1950's.

Subsequent work implicated polyamines in the regula¬

tion of cellular growth and nucleic acid metabolism.
Although seminal fluid occupies a special place in the history of
the polyamines,

little is still known of their function there.

(at 5 to 50 mM, the predominant polyamine in semen)
sential to sperm motility and survival.

Spermine

is probably not es-

However, semen does contain
/: r

a diamine oxidase which oxidizes spermine to a bacteriostatic aldehyde.
The bull has no prostate to secrete polyamines, and bull semen, contain¬
ing less than 1% as much spermine as human semen,
with microorganisms including gonococci.^

is notoriously infected

Incidentally, these oxidized

products of spermine may impart to human semen its peculiar odor, des¬
cribed by John Hunter in 1786 as "mawkish and unpleasant, exactly
resembling that of a Spanish chestnut.

Polyamine Biosynthesis
Synthesis of polyamines in both prokaryotes and eukaryotes

3
proceeds from amino acids.
polyamine synthesis

Probably the rate-limiting step in mammalian

(and the only biosynthetic step proceeding from

ornithine) is the decarboxylation of L-ornithine to form putrescine and
carbon dioxide (Figure 1), catalysed by ornithine decarboxylase (ODC)
(EC 4.1.1.17).^^^

Ornithine is provided by the action of arginase on

arginine, even in cells lacking other urea cycle enzymes.

E.

coli and

mycobacteria can synthesize putrescine from arginine via agmatine, in
addition to the ODC route.^6

a further detour from agmatine through

N-carbamoyl putrescine is followed by certain higher plants.However, neither of these latter alternatives is important in mammals.

193

Putrescine accepts an aminopropyl group from decarboxylated
S-adenosyl methionine (SAM) to form spermidine.

(This respresents an

unique role for SAM, which is well-known as a methyl donor in prokaryotic
transmethylations.)

The first step in this sequence is the activation

of L-methionine by coupling with ATP to give SAM, which is next decarb¬
oxylated and finally relieved of its aminopropyl group.

Spermine is in

turn formed by the addition of an aminopropyl group to spermidine; sper¬
mine is not synthesized by prokaryotes.

SAM-decarboxylase, spermidine

synthase, and spermine synthase now appear to be three easily separable
enzymes, ^4 contrary to earlier suggestions that a single enzyme complex
performed all three functions. 24,137,181

decarboxylation of SAM is

markedly stimulated by putrescine, less so by spermidine, in eukaryotes;
no such effect is observed in prokaryotes. ^ > ^7
The work of Gale and of Morris and Pardee revealed two kinds
of _E.

coli ODC:

an induced, catabolic enzyme, and a constitutive, bio-

synthetic enzyme, differing in heat stabilities and pH optima,

43 171

’

4
However, mammalian ODC from numerous sources are all alike, resembling
the rat liver ODC in the following properties:
1.

product inhibition, to various degrees,

by putrescine,

spermidine, and spermine;1^2,136,195
2.

a Km for ornithine of about 0.1 - 0.2 mM,^,143,193 and

specificity for L-ornithine;
3.

14 3

a requirement for pyridoxal phosphate but not for cations,

and inhibition by isonicotinic acid hydrazide;
4.

a tendency to polymerize to a catalytically inert form in
Q O

the absence of thiol compounds.
paradoxical effect in that at
inhibits the enzyme.

O T

’
high

I Q C

>

Dithiothreitol displays a

concentrations it competitively

Mercaptoethanol, at similarly high concentrations,

maintains a consistent level of activation.
5.

14 3

a pH optimum around 7.4 - 8.1

41
This optimum was originally

reported to shift to the more alkaline side with higher mercaptoethanol
concentrations^^

but this does not occur with the purified enzyme.^1

Most studies on ODC, however, use the crude enzyme.
Both ODC and SAM-decarboxylase are soluble, but their normal
intracellular localizations are unknown.

In stimulated rat liver, 90%

of ODC activity-*-^" and 50% of SAM-decarboxylase activity-*-^ are found
in the soluble fraction of the cell, the remainder of activity being
mainly nuclear with 2 to 3% microsomal.

Regulation of ODC Activity
ODC displays characteristics, particularly a short half-life,
which suggest tight cellular control over enzyme activity.

Russell

5
and Snyder obtained a half-life of 10 to 11 minutes for liver ODC by
testing activity at short time intervals after injecting cycloheximide
or puromycin into partially hepatectomized rats,^7,1^2 or CyCloheximide
into rats pretreated with growth hormone'*"'^ or 17 3-estradiol.

jn a

separate experiment in which no inhibitors of protein synthesis were
used, growth hormone was administered and the half-life was calculated
from the downslope of the ODC activity curve to be 24 minutes.1^9
this latter figure is probably an overestimate,

As

it confirms the finding

that ODC has the fastest turnover of any mammalian cellular enzyme yet
characterized.

These figures compare with a t^ of 67 to 72 minutes for

6-amino levulinic acid synthetase

(previously thought to be the enzyme

with the briefest activity); 2.0 hours for ribonucleotide reductase;
and 4 to 5 days for arginase.

17?

Several mechanisms may explain the swift decline in ODC activity.
In two animal systems recently studied, the half-life of ODC changed
rapidly together with total enzyme activity, with the half-life greatest
in stimulated cells undergoing division and shortest in inhibited
cells.

5°u

Thus enzyme inactivation might be important in the regula¬

tion of ODC activity.

Inactivation may come about through an energy-

requiring degradation of enzyme protein, as is suggested by the finding
that dinitrophenol lengthens the half-life of ODC in insulin-stimulated
mammary tissue from 18 minutes to one hour.

Putrescine, spermidine, and

spermine have recently been shown to induce the synthesis by cultured
rat hepatoma cells,^ mouse leukemia cells, and neuroblastoma cells'^
of a protein (dubbed an "antizyme") which non-competitively inhibits ODC
from each of these sources.

This observation is exciting in that the

6
"antizyme" appears to represent a previously undiscovered mechanism for
enzyme regulation.

This mechanism might also explain the earlier ob¬

servation that the injection of putrescine^ ’165 Qr Spermicjine70
specifically prevent the rise in ODC activity in regenerating rat
liver, and that putrescine or spermidine block the ODC rise in cul¬
tured 3T3 cells.
Among the other factors which have been found to affect ODC
activity are microtubular structure^ and changes in cellular cation
pools.

21

Putrescine, and to lesser degrees spermidine and spermine,

are weak competitive inhibitors of ODC.^^2,136,195
It has been widely suspected that cte novo synthesis of enzyme
protein plays a role in cellular control of ODC activity, based mainly
on findings in numerous systems that inhibitors of protein or RNA syn¬
thesis will prevent the stimulatory response of enzyme activ¬
ity;

131,149,202 tjlus

has bggH proposed that polyamines block

ODC stimulation by selective inhibition of the translation of the
O T

enzyme.

1

Of.

0,100

Early work with antibodies to rat liver ODC has lent

support to this speculation.18,62,187

Polyamines and Growth
The conditions under which polyamine levels are observed to
rise suggest a relationship between these amines and growth processes.
In man and other animals, tissue putrescine levels are very low, and
spermidine is usually found in slightly higher concentration than
spermine,154

Levels vary with organ and with age in the rat,

spermi¬

dine levels dropping significantly after one month while spermine levels
remain relatively constant so that the spermidine:spermine ratio falls

7
sharply from birth.^
The polyamine content of chick embryos is highest directly
after fertilization and again at day 15 of an 18-day incubation,
closely paralleling the two known RNA peaks, less closely matching
DNA rises; 141 peak ODC activity in chick embryos occurs at 5 days.158
Moruzzi, et al., manipulated polyamine levels in chick embryos and
observed effects on polyribosomal profiles, polymerase activity, and
nucleic acid label incorporation.

They found that increasing polyamine

concentration by inhibiting amine oxidase with iproniazid led to in¬
creased ^H-orotic acid incorporation into both RNA and DNA and into
larger ribosomes; a decrease in polyamine concentration with increased
amine oxidase activity led to decreased incorporation.
pecially true for nuclear DNA and ribosomal RNA.

This was es¬

They further found

that DNA-dependent RNA polymerase activity varied in the same manner with
I OO

changes m polyamine concentration.
Regenerating rat liver--The relationship between polyamines and nucleic
acid synthesis has been most thoroughly characterized in regenerating
rat

liver

after partial hepatectomy, but has also been described in

conditions of renal^8 and cardiac^’^'* * * * * * 7 hypertrophy in the rat, as well
as in endocrine target organs, as described later.
Dykstra and Herbst in 1965 first reported that spermidine levels
are highest 48 to 72 hours after partial hepatectomy, closely approx¬
imating the increased rate of synthesis of RNA in regenerating rat
7 7

liver.

Raina independently reported a rise in spermidine synthesis,

measured by 14c_met]1ionine incorporation into spermidine, as early as
4 to 8 hours after the operation; spermidine was highest at 64 hours.

8
Spermine began to rise only at 16 hours.

The ratio of polyamine nitro¬

gen to RNA phosphate remained virtually constant through these changes,
but correlation with DNA phosphate was less close.442
Work on polyamine turnover rates also supports the view that
the functions of spermidine in particular are closely allied to those
of ribosomal RNA, for in the normal and regenerating liver both spermidine and rRNA have half-lives of 4 days.

1

??

Interestingly, although Raina and Janne found a marked increase
in 14c incorporation into spermidine from labelled methionine following
partial hepatectomy, they could demonstrate no such stimulation of 14c
incorporation from labelled putrescine under the same conditions.^6>142
These authors demonstrated a sharp increase in ODC activity in regen¬
erating liver, accounting for an accumulation of endogenous putrescine,
thus explaining increased spermidine synthesis without utilization of
exogenous putrescine.
in this

^4

system.

Putrescine levels closely follow ODC activity

Russell and Synder found ODC activity to rise to 22

times control levels at 16 hours after partial hepatectomy, a dramatic
rise for a mammalian enzyme.

Of five other L-amino acid decarboxylases

tested in the same livers, none changed in activity.

Within one hour

following operation, the ODC activity tripled, making this the earliest
enzyme change in regenerating liver; the 16 hour peak in ODC activity
precedes the peak increases in RNA and DNA synthesis.458
When rats are divided according to age it becomes clear that the
ODC rise in regenerating liver is in fact biphasic, the second peak
nearly coinciding with the first in young rats but becoming more
clearly delayed with age.

fid

Both increases require protein synthesis.

9
but only the first one is dependent on RNA synthesis, the second appar¬
ently being the result of translation from RNA synthesized during the
first phase.^

Hypophysectomy considerably delays but does not prevent

the ODC rise in regenerating liver, suggesting that the first peak is
more hormone-dependent than the second; adrenalectomy, castration, or
thyroidectomy have no such effect.

173

Hormonal regulation of ODC

activity in liver and elsewhere is discussed in a later section.
The response of SAM-decarboxylase to partial hepatectomy in the
rat

is

of much lesser magnitude and expressed only much later than the

ODC stimulation, and older rats do not respond to this stimulus with a
change in SAM-decarboxylase at all.^^

Synder, et al., were unable to

label polyamines from l^c-o^i-thine in normal liver because the resting
rate of putrescine synthesis was so low, while they had no such trouble
with the -^C-putrescine to spermidine conversion.

These two findings

suggest that in the rat liver SAM-decarboxylase is responsible for main¬
taining the constant pool of spermidine, and that the step catalysed
by ODC is rate-limiting in the unstressed liver.

Subcellular Effects of the Polyamines
The discovery of an association between polyamine accumulation
and nucleic acid synthesis raises the possibility that the relationship
may be more than coincidence.

Polyamines have been reported to affect

nucleic acid metabolism in a variety of ways.

A.

Macromolecular stabilization
Nucleic acid phosphate groups are highly acidic, and structures

containing them are greatly stabilized by polycations.

In the T4 phage.

10
putrescine and spermidine account for 40 to 50% of the identifiable
cation, the remainder being mainly magnesium.^

Watson points out that

in rapidly growing E. coli, the intracellular magnesium concentration
is sufficient to neutralize only about half the RNA phosphate negativ¬
ity, and that polyamines probably make up the difference.

Poly¬

amines complex strongly with nucleic acids and polyribonucleotides.^
1.

DNA stability.

Polyamines, especially spermine, stabilize

DNA against thermal^^»l^O ancj enzymatic degradation, primarily by re¬
versibly binding to nucleic
2.

RNA stability.

acid.

^*^9

As with DNA, spermine is the most effective

polyamine in protecting RNA against thermal

47 119
55
’
and enzymatic
de-

gradation, again probably by binding the nucleotide.
high concentrations inhibit ribonucleases,
in fact enhance enzyme activity.
3.

Ribosomal structure.

of ribosomes both m bacteria

1 08

37

Polyamines m

although low levels may

107
Polyamines promote subunit aggregation
and m eukaryotes,

’

and

also promote binding of rat liver ribosomes to endoplasmic reticulum,
rendering the ribosomes more resistant to ribonuclease.

91

Polyamines

may also inhibit enzymatic degradation of ribosomes by maintaining the
intact ribosome and preventing ribonuclease release.

36

Polyamines can substitute for magnesium in several of its func¬
tions iii vitro.

In prokaryotes polyamines can replace magnesium, al¬

though protein synthesis appears to require the presence of a minumum
amount of magnesium.

It was recently found that during the log¬

arithmic phase of growth in E. coli, ribosomal contents rise in con¬
cert with spermidine and putrescine, while magnesium levels change

11

little.70

Polyamine stabilization of ribosomes may be a key to the

ability of thermophilic bacteria to function at high temperatures.

B.

177 177

^/,x//

Macromolecular function
1.

DNA synthesis.

While polyamines have been reported to

stimulate DNA synthesis in some systems,13,166 they are inhibitory
in others,1-0,100 the effect apparently varying with the template.1^0
2.

RNA synthesis.

Polyamines stimulate RNA polymerase from

prokaryotes1’00 and mammals17»70584510- in vitro, probably by binding
the RNA and preventing product inhibition.1,00

Spermidine also stabil¬

izes the transcription complex, thereby increasing chain length and
elongation rate.04,84
3.

tRNA processing.
a.

methylation.

Spermine, spermidine, and putrescine pro¬

foundly enhance tRNA methylation in vitro, and are even more effective
than magnesium.100
to tRNA

48

This effect may be the result of polyamine binding

and may involve a competition between polyamine and some

inhibitor.101

In regenerating liver tRNA methylation does not appear

to correlate with polyamine levels;

167

however, total cell levels may

not reflect subcellular distribution of polyamine--as,

for example, in

cultured mouse fibroblast ribosomes where the spermidine:spermine ratio
rises significantly during exponential growth although the ratio for
the entire cell remains unchanged."^
As SAM serves as a methyl donor in these reactions, it seems
not unreasonable to speculate about possible interrelationships between
polyamine synthesis and tRNA methylation.

'

12
b.

aminoacylation.

Polyamines, especially spermine, en¬

hance tRNA aminoacylation in prokaryotes.^^^

The mechanism had

been thought to involve binding of RNA by polyamines,

but recent

evidence suggests that spermine acts by displacing magnesium from
tRNA,

thereby
4.

promoting

162

aminoacylation.

protein synthesis.

Polyamines can reduce the requirement

for magnesium in protein synthesis by ribosomes from a variety of
mammalian^®’ ^4 ancj bacterial ^5 28,42,114,182 S0urceS} and while the
magnesium requirement is in no case eliminated, polyamines are nec¬
essary for maximal protein synthesis in several systems.^>^8>^8
The mechanism seems to involve

enhancement

of aminoacyl-tRNA binding

to ribosomes5 183,185
It is worth noting that for stimulation of tRNA methylation,
tRNA aminoacylation, and protein synthesis, spermine is more effective
than spermidine, with putrescine least so; this is precisely the order
A O

of avidity of these amines in binding to tRNA.

C.

Other Subcellular Effects
1.

membrane effects.

Polyamines protect bacteria,

112

bacterial protoplasts^"> ^9 ancj mitochondria"*^ from the effects of
hypotonicity, by binding to membranes.^>^2,145

Spermidine and spermine

stabilize rat liver microsomes in vitro, thus enhancing the 2-hydroxylaor

tion of estradiol.
2.

effects on carbohydrate metabolism.

Spermidine and sper¬

mine exert several effects on adipocytes which mimic the effects of
insulin, including stimulation of glycolysis, inhibition of lipolysis.

13
enhancement of glucose uptake, and blockage of the activation by
epinephrine of adenylate cyclase.

4

These effects are membrane-mediated,

though not through the insulin receptor.

1 09

Polyamines also directly activate certain enzymes in_vitro,
including phosphoenolpyruvate carboxylase,164 glycogen phosphorylase b
(in the presence of AMP),1^ and glucose-6-phosphate

D.

dehydrogenase.16^

Inhibitor Studies
Although the evidence for an association between polyamines

and growth is diverse and extensive, it is largely circumstantial.
One cannot conclude from observed in vitro effects of polyamines or
correlations with other events that they do play an important physio¬
logical role, nor can one infer whether any cellular function is truly
regulatory, or permissive, or whether the relationship is coincidental.
The

very

breadth of functions that have been reasonably proposed for

polyamines seems to preclude any simple assessment of their true func¬
tion.

Inhibitor studies have offered the hope of defining the role of

polyamines, but to date have had only mixed success.
Methylglyoxal bis

(guanylhydrazone)

(MGBG) inhibits the pro¬

liferation of L1210 leukemia cells in mouse hosts, an effect which is
1 1 O

counteracted by spermidine.

°

The compound was shown to be a specific

inhibitor of SAM-decarboxylase.1^6

Studies on regenerating rat liver

failed to reveal inhibition of spermidine accumulation by the drug, nor
any change in nucleic acid synthesis.

6

3

In mouse parotids, MGBG blocks

the rise in gland weight and in DNA synthesis in response to stimulation
by isoproterenol.^

Kay and Pegg reported that MGBG blocked spermidine

4

14
synthesis in PHA-stimulated lymphocytes, with inhibition of thymidine
o/:

incorporation into DNA and phenylalanine incorporation into protein.
Concentrations of MGBG used in this experiment were shown to be sev¬
eral hundred-fold larger than necessary to inhibit spermidine formation,
and to inhibit directly protein synthesis.

39

Nevertheless, protein

and DNA synthesis were restored by the addition of spermidine.
Fillingame and Morris showed that RNA accumulation begins prior to
rises in polyamine levels in Con-A stimulated lymphocytes, and that low
concentrations of MGBG blocked spermidine and spermine accumulation
without altering total RNA synthesis, RNA sucrose-density gradient
profiles, or the rate of RNA turnover. ^9

However, in their and other

studies, MGBG led to enhanced ODC activity and to marked rises in
putrescine levels.39>63

^he drug has also been shown to prolong greatly

the half-life of SAM-decarboxylase and to inhibit diamine oxidase.

63

Alpha-hydrazino ornithine (aHO) selectively inhibits ODC activ¬
ity in vitro^ and blocks putrescine synthesis in cultured rat hepatoma
cells and in regenerating rat liver without appreciably affecting the
synthesis of either RNA or DNA.^
-amino-valeric acid (DL-HAVA)

6

The racemic form of aHO, DL-ahydrazino-

is a more potent inhibitor of ODC activ¬

ity than aHO, and blunts the putrescine rise in isoproterenol-stimulated
mouse parotid glands; this is associated with inhibition of DNA syn¬
thesis and mitotic activity which is reversed by putrescine.
authors thus propose a role for putrescine in DNA replication.

The
It

must be noted however that DL-HAVA prolongs the half-life of parotid
ODC,^ and that both compounds can enhance ODC activity;^>^3 conclu¬
sions from their use should be guarded.

15
Without inhibitors, similar information was obtained by Morris,
using a mutant of E.

coli deficient in arginine decarboxylase and thus

blocked in one of its pathways of putrescine synthesis and dependent
on exogenous putrescine for normal growth.

During putrescine starvation,

cell growth rate dropped almost by half, with proportionate decreases in
elongation rates of RNA and polypeptides, which are corrected by poly¬
amine repletion.

No changes in RNA size distribution, methylation, or

turnover were observed.

However, this system differs significantly

from eukaryotes both in polyamine biosynthesis from amino acids and
in nucleic acid metabolism; no comparable work has been done with
mammalian cells.

Hormonal Effects on Polyamine Synthesis
The discovery in the late 1960's that polyamine levels in sev¬
eral tissues depend on hormonal stimuli prompted much work on the reg¬
ulation of polyamine metabolism in endocrine target organs.
peptide hormones

(TSH,

as well as steroids

LH, ACTH, growth hormone, insulin, and glucagon)

(including estrogens and testosterone), which pro¬

mote growth of target tissue, also stimulate ODC activity.
of cyclic AMP (cAMP)

Poly¬

The role

in this stimulation appears not to be as clear as

was once thought.

A.

Target Tissues
1.

Liver.

Kostyo in 1966 found that liver spermidine levels

are reduced after hypophysectomy, but can quickly be restored by the
administration of growth hormone.^

As in regenerating liver,

putrescine and spermidine synthesis^ and ODC

activity^

are stimulated

16
by growth hormone while spermine content remains essentially un¬
changed, 76,95 and SAM-decarboxylase activity rises less and later
than ODC.80
The time course for spermidine synthesis from labelled meth¬
ionine after a single injection of growth hormone is similar to those
for enhanced RNA and protein synthesis.

ODC activity and nuclear

RNA polymerase activity rise together after growth hormone adminis¬
tration, and they differ from other hepatic enzymes such as tyrosine
transaminase whose activities are also somewhat elevated by growth
hormone but which are also affected by fasting and adrenalectomy.

81

Other hormones found to enhance hepatic ODC activity include
hydrocortisone,135 dexamethasone,H and insulin,133 anj to lesser
degrees glucagon&f3’ 153 and thyroxinel^3; aii give peak enzyme activ¬
ity at 3 to 4 hours after stimulation.
Hormonal stimulation of ODC activity is duplicated by dibutyryl
cyclic AMP (dbcAMP)H>66 or by phosphodiesterase inhibitors;H>16 ele¬
vation of ODC activity by aminophylline or theophylline is preceded by
a rise in hepatic cAMP.16

Ln vivo studies must be interpreted with

caution, as dbcAMP and theophylline have been reported to cause release
of pituitary growth hormone,59 and larger amounts of dbcAMP are re¬
quired to elevate liver ODC activity after hypophysectomy. 1^
2.

Adrenal.

Adrenal ODC activity is induced in a dose-

related manner by adrenocorticotropic hormone
rats.106,149

(ACTH)

in hypophysectomized

DbcAMP also gives dose-related ODC stimulation.1^

steroidogenic portion of the ACTH molecule (peptides 1-24)

The

is fully

effective in stimulating ODC activity, 1*15 but this is not secondary to

17
steroids themselves,

for hydrocortisone has no effect, 149 anc[ inhibitors

of steroidogenesis do not block the ODC response to ACTH. ^6
A single subcutaneous injection of ACTH causes a rise in
adrenal cAMP levels within 30 minutes, which fall to normal within
an hour.105, 149

Richman et al. reported that with increasing doses

of ACTH, cAMP levels continued to rise beyond those giving maximal
steroidogenesis; at this higher cAMP range, ODC activity increased in
parallel
disputed

with
106

).

intracellular cAMp!49 (although this finding has been
Thus these higher levels of ACTH might serve to promote

growth through ODC.149
Aminophylline or exposure to cold leads to cAMP accumulation at
30 minutes and ODC stimulation by 4 hours in both the medulla and cortex
of rat adrenals.

Splanchnicotomy abolishes these responses in the

medulla but not in the cortex.^
There is a progressive fall in adrenal ODC responsiveness to
ACTH after hypophysectomy.

’ 106

Cycloheximide blocks the ODC rise

with ACTH in rats treated either one or 16 hours after hypophysectomy,
but actinomycin D was only effective in the one-hour rat, suggesting
that adrenal ODC induction requires transcription of new protein and,
in the chronically hypophysectomized rat, translation of mRNA as well.1^6
Both agents block the stimulation of adrenal ODC by cold exposure or
aminophylline without affecting the cAMP rise.H'
The time

lag

between rises in cAMP levels and ODC activity

and the inhibition of ODC stimulation with actinomycin D and cyclohexi¬
mide suggest that the stimulation represents new synthesis either of
enzyme protein or of an effector of the enzyme.

Direct phosphorylation
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of the enzyme probably does not occur. ^9
Growth hormone gives dose-related stimulation of adrenal ODC
with a time course similar to that with

105 but does so without

ACTH,

altering cAMP levels.GH and ACTH are synergeistic in elevating
ODC activity.105

Thus there may be a second mechanism controlling

adrenal ODC activity in addition to that mediated by cAMP.
The only in vitro study of adrenal ODC revealed marked enhance¬
ment of enzyme activity in isolated adrenal cells with incubation alone.
This stimulation was halved by the addition of ACTH, cyclic AMP, or
corticosterone.

The authors proposed that ACTH and cAMP may inhibit

ODC activity via corticosterone.1^8
3.

Testis.

In the rat testis,

the specific activity of ODC

is maximal by 3 days of age, at which time the seminiferous tubules
contain only Sertoli cells.
parallel ODC activity.

Spermidine levels, after some delay,

SAM-decarboxylase, in contrast, rises slowly

after birth to a plateau corresponding to the time at which spermatids
mature.

The hypothesis that ODC activity resides predominantly in Ser¬

toli cells is supported by albumin density gradient separation, which
leaves nearly all the ODC activity in the dense Sertoli layer.m
Hypophysectomy dramatically reduces testicular ODC activity,
which can be restored by FSH,

LH, or testosterone.m

Stimulation of

ODC activity by FSH and LH can be mimicked by cAMP but for a briefer
period; cycloheximide blocks the effects of these latter three
agents.

146

4.

Prostate.

The prostate is unique among organs in that it

secretes large amounts of polyamines in semen, and therefore has the
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highest specific content of spermidine and spermine. 193 > 194
Castration reduces, and testosterone fully restores, polyamine
levels and ODC activity in rat ventral prostate. 1^3,135

Spermidine is

here the most labile of the polyamines,1^5 its changes correlating
I 07

well with changes in RNA levels,

although time-sequence studies

suggest that this more likely reflects a coupling between RNA and
polyamine biosynthesis than a causal relation.193

SAM-decarboxylase

activity varies with the same time course and, unlike in other organs,
to the same degree as ODC activity with castration, hypophysectomy,
and testosterone.

Spermidine levels behave in seminal vesicles as in

prostate.
5.

Ovary.

Adult rats normally exhibit cyclic changes in
Q Y

ovarian ODC activity, which rises on the afternoon of proestrus.

°

This rise can be reproduced by parenteral Lh69?88,93,99,117 or
HCG;

’

5

J further , the normal cyclic elevation in ODC activity

can be prevented by prior injection of antiserum to LH^ or of pentoO O

barbital, which blocks the release of LH from the pituitary.

This

Q Y

stimulation is specific for gonadotropins.

As in other stimulated

organs, ODC activity peaks at 4 hours after gonadotropin admin¬
istration. 88,93,99
Luteotropin stimulation of ODC activity can be duplicated with
prostaglandin E2, but this may be due to the release of LH seen in vivo
after administration of the prostaglandin.^

The rise in ODC activity

after LH or HCG can be prevented by pretreatment with cycloheximide
antinomycin D

8 S 11 7
’
and,

for LH, with puromycin as well.

oo

The activity of SAM-decarboxylase is constant through the estrus
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cycle and after LH;

117

it barely doubles with a dose of HCG sufficient

to give 12-fold elevation of ODC activity.
6.

Uterus.

igz

In ovariectomized rats, estradiol causes signif¬

icant elevation of uterine spermidine, paralleling rises in DNA con¬
tent. 1^3

uterine ODC activity rises to peak levels 4 hours after
o /:

parenteral 173-estradiol

o-7

’

but not if cycloheximide or puromycin is

administrered two hours after estrogen.

87

Non-steroidal estrogens in-

eluding diethylstilbestrol induce ODC as well.

87

The stimulation by

173-estradiol is accompanied by no changes in cAMP levels.
ODC activity changes cyclically in the rat uterus, being highest
at proestrus,

S7 87
’

'

paralleling estrogen levels.

87
'

Polyamine levels and

polysome aggregation are also greatest during proestrus, but a causal
relationship is argued against by the rapid fall of the latter one day
earlier than the former.

57

Both 173-estradiol and DES give marked enhancement of oviduct ODC
activity at 4 hours.

Hypophysectomy and castration do not alter this

response, but it is reduced by 80% with cycloheximide.

The stimulation

is also seen in vitro with incubated oviducts, with complete inhibition
by cycloheximide.

Progesterone gives a small elevation of oviduct ODC

activity in vivo.26
7.

Mammary tissue.

Lactation in the rat is accompanied by

elevations in mammary ODC and SAM-decarboxylase activities, and by a
rise in the spermidine:spermine ratio which parallels rises in RNA
content.156

Cell differentiation and milk protein synthesis in mammary

tissue iii vitro depend on a combination of insulin, glucocorticoid, and
prolactin;-^-30

the latter process is preceded by 3-fold elevations in
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spermidine.

Spermidine, but not putrescine, spermine, or magnesium,

can replace hydrocortisone required for milk protein synthesis.

Inhib¬

ition of spermidine synthesis by MGBG also blocks the synthesis of milk
proteins, which can be restored by exogenous spermidine.128,130
such in vitro systems,

with

insulin has been shown to stimulate ODC activ¬

ity, ^ insulin with hydrocortisone to stimulate SAM-decarboxylase activtivity,130 and prolactin to stimulate the activity of arginase in these
cells with no urea cycle.The stimulation of arginase probably serves
to supply ornithine for polyamine biosynthesis, for in arginase-poor
medium lactogenesis does not occur but can be reinstated by adding
ornithine, putrescine, or

.^^

spermidine

It thus appears clear that

polyamines play an important role in protein synthesis in this system.
Incubation of mammary tissue leads to an early transient rise
in ODC activity which is independnet of hormonal stimuli (though en¬
hanced by hormones) and is associated with a brief elevation of cAMP.
A second ODC peak at 12 hours depends on insulin and prolactin.

The

second peak requires both transcription and translation, though control
of the first peak is post-transcriptional.-*^1

Insulin and prolactin

do not affect cAMP levels despite enhancement of ODC activity with
these hormones, and the two are additive in effect with dbcAMP,-*^
again suggesting a cAMP-independent pathway for enzyme stimulation.
Epidermal growth factor also stimulates mammary ODC activity.*^
Prolactin stimulates ODC activity in rat kidney, adrenal,

liver,

and to some extent thymus and heart, in vivo; this finding lends sup¬
port to the view that the hormone has several target tissues.147
8.

Epidermis.

Edpidermal growth factor is a polypeptide iso¬

lated from mouse submaxillary gland that has recently been shown to

/
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stimulate the proliferation of epidermis and possibly other epithelia,
and thus is a hormone by Huxley's definition.

ft R
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One parameter of its

biological activity is its stimulation of ODC activity in mouse skin
in vivo;

it also causes a transient, translation-dependent rise in ODC

activity in cultured chick embryo epidermis.

1 7 f)
/D

ODC activity parallels

DNA synthesis in mouse hair follicles during normal cyclic hair growth
and when stimulated by plucking the hair.-*-40
9.

Kidney.

Renal ODC activity varies diurnally in the rat,

corresponding to variations in plasma corticosteroids, although vari¬
ations in growth hormone secretion were not measured.

Hypophysectomy

reduces enzyme activity to a constant low level which can be restored
best by growth hormone, but also by ACTH and cortisol.

Thus renal ODC

activity is dependent primarily on growth hormone, and probably on corti¬
costeroids as well 2^^
10.

Thyroid.

A single injection of TSH results in marked stim¬

ulation of thyroid ODC activity peaking at 4 to 6 hours.^^5150,202
This stimulation is specific, ^02 dose-related,-*-^0 and inhibited by
cycloheximide and actinomycin

d.

1^0,202

The half-life of the thyroid

enzyme as estimated by the decline in activity following cycloheximide
is about 15 minutes.-*--*-^
TSH.

202

Hypophysectomy blunts this ODC response to

Inhibitors of prostaglandin synthesis such as indomethacin

inhibit the rise in ODC activity with TSH

202

in a dose-related

fashion-*^ with diminution in thyroid prostaglandin levels, but this
inhibition is not overcome by exogenous PGE2, nor does this prostaglandin
stimulate ODC activity in thyroids of normal rats in doses sufficient to
stimulate adrenal ODC activity.The ODC stimulation is also inhibited

23
by the microtubule antagonists colchicine and vinblastine.

There

is recent evidence that thyroxine and triiodothyronine diminish the
ODC response to TSH, representing a possible 'short-loop' negative
feedback as part of thyroid regulation

1 99

Aminophylline or dbcAMP alone are unable to stimulate ODC
activity,

1

so ?n?
’
but in combination gave 12-fold stimulation as re¬

ported by Zusman and Burrow,202 although another group using identical
dosages observed only minimal elevation in ODC activity. ^5,150
Treatment with goitrogens leads to increases in thyroid ODC
activity with a peak at 2 to 4 days; enzyme activity declines there¬
after despite continued elevation of serum TSH.^°

Putrescine and

spermidine levels rise until the seventh to tenth day of treatment,
spermine remaining constant.
matches the RNA:DNA ratio.

The spermidine:spermine ratio closely
SAM-decarboxylase activity rises with

treatment with methylthiouracil, though the increase is much less than
that of 0DC.H°
Thyrotropin-releasing hormone gives dose-related stimulation
of ODC and SAM-decarboxylase activities in the thyroids of intact rats.^^

B.

Role of Cyclic AMP
It is now clear that in a number of tissues the stimulation of

ODC activity is mediated by cyclic AMP.

The administration of exogenous

dibutryrl cyclic AMP leads to elevations in ODC activity in rat liver, ^->66
adrenal,

149
.
13S
13°
‘ and testis,
as well as in quail oviduct with the same time

curve as stimulation with non-steroidal hormones.

1 39

DbcAMP has the

same effect in vitro with cultured hepatoma,^2 glioma,^ and baby hamster
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kidney^1 cells.

Further, polypeptide hormones such as

Tsh}150,202 glucagon,^’

^5105,148

ACTH,

FSh}^3,135 and LH,^>93,99,117,123,135 known

to affect cell metabolism through increases in cAMP levels, also stim¬
ulate ODC activity in their target organs.
been examined,

Where the time course has

cAMP elevations invariably precede rises in ODC activ¬

ity, as seen in rat adrenal after ACTH1^ > 105»and in rat liver,
kidney, and adrenal after aminophylline or theophylline.

1

ft

In synchron¬

ized Chinese hamster cells, elevation of cAMP levels in late G^-early S
phase are followed by stimulated ODC activity peaking in mid-S phase,
with subsequent accumulation of polyamines during late S-G2.
On the other hand,

OL

steroids appear to control ODC activity via

mechanisms independent of cAMP.

In the rat uterus,

178-estrodiol stim¬

ulates ODC activity without affecting cAMP levels, although ODC activ¬
ity is sensitive to cAMP elevations as well, as evidenced by the rise
in ODC activity in the same system with isoproterenol, a known stimu¬
lant of uterine adenylate cyclase.

The effect of isoproterenol on

ODC, but not that of estradiol, is blocked by propranolol.
AMP, dbcAMP,

201

Cyclic

173-estradiol, and diethylstilbestrol all enhance ODC

activity in quail oviduct, but the response to estrogens is higher and
more prolonged than the effect of the nucleotide

(although in this

experiment only one concentration each of cAMP and dbcAMP was tested).
Dexamethasone and dbcAMP stimulate ODC activity in cultured
rat hepatoma cells, but while the stimulation with dexamethasone is
blocked by actinomycin D (and not by spermine), the stimulation with
cAMP is not blocked by actinomycin D (and is prevented by spermine)
Thus dexamethasone seems to enhance ODC activity in this setting through
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a mechanism different from cAMP, the latter apparently acting at a posttranscriptional level.
Further,

insulin, which lowers hepatic cAMP levels, ^31 stim¬

ulates liver ODC activity.

33

Insulin enhances ODC activity in baby

hamster kidney cells^ and, when combined with prolactin,

insulin

elevates ODC activity in mammary explants without altering cAMP
levels,although in both systems the response to insulin is enhanced
by the addition of

dbcAMP.>131

Thus, most polypeptide hormones appear to stimulate ODC activ¬
ity through the mediation of cyclic AMP, while steroids and insulin do
so by other means.

In one preliminary report, dbcAMP in a dose suf¬

ficient to increase hepatic glucose output, reduced ODC activity in
perfused rat livers,

Responses to cAMP derivatives are usually

highly dose-dependent!31 and this confusing result might be explained
by the choice of dose.

Thyrotropin and Thyroid Metabolism
The function and growth of thyroid follicular cells are con¬
trolled primarily by circulating thyrotropin (thyroid stimulating
hormone, TSH), a glycoprotein secreted by the anterior pituitary.
hormone binds specifically to receptor sites on the thyroid plasma
'Z O

membrane and activates adenylate cyclase,

resulting in elevation

of cAMP concentration together with activation of protein kinase.
A large body of evidence supports the view that many of the effects
of TSH on the thyroid cell are mediated by cAMP.

Interpretation

of the effects of TSH on thyroid metabolism is complicated by the

This

■

'
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variability in time responses of cells within a thyroid to a single
administration of TSH; by the differing responsiveness of thyroid cells
from various species to a given stimulus; and occasionally by the dif¬
fering effects of small and large doses of TSH.

Nevertheless, many

stimulatory effects of TSH have been well characterized both in vivo
and in vitro.

D

Role of Cyclic AMP
The earliest change induced by TSH is an increase in thyroid
cAMP content,
bation,

45

seen in beef thyroid slices within three minutes of incu-

and within ten minutes in rat thyroid lobes

thyroid cells.

188

and calf

Doses of TSH which enhance cAMP accumulation are

usually in the range at which other effects of TSH are seen,’^5,46,192
although in some systems TSH continues to elevate cAMP levels at doses
above those needed to produce colloid droplet formation, iodide re¬
lease, and other physiologic effects;^>192 for exampie, in incubated
mouse thyroids, colloid droplet formation is maximal at 3 mU/ml TSH,
while cAMP levels continue to rise with increasing TSH concentrations,
peaking at 30 mU/ml.

The role of this further accumulation of cAMP

is not known.
The elevation of cAMP levels is due to activation of adenylate
cyclase, which has been observed in dog thyroids within three minutes
of TSH injection in vivo.^^ phe dose-response curve for TSH binding
to thyroid plasma membrane virtually coincides with the one for
adenylate cyclase activation; both are half-maximal at about 15 mU/ml
and maximal at 75 mU/ml. 38
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Cyclic AMP is thought to act intracellularly through the acti¬
vation of protein kinases, with dissociation of the catalytic and reg? O

ulatory subunits.

Cyclic AMP-dependent protein kinases have been

demonstrated in thyroid homogenates, and behave similarly to kinases
from other tissues. ^4

ppe dose-responses of protein kinase activa¬

tion and cAMP accumulation with TSH are compatible with the proposed
mechanism.

To date, substrates for protein kinase have not been

identified in the

38

thyroid.

Cyclic GMP (cGMP) appears to be less stimulated than cAMP by
TSH, and is probably less important in mediating its effects.

Thyro¬

tropin seems to affect more the intracellular localization of cGMP
than its levels, with cGMP redistributing to cytoplasm from membranes
upon stimulation.

Cyclic AMP by contrast appears to be less affected

in its distribution.

It is possible that CGMP is involved in the reg¬

ulation of thyroglobulin iodination.38

Effects of TSH on Thyroid Activity
Within minutes of injection with or incubation in TSH, and to¬
gether with or soon after the rise in cAMP levels, there is enhancement
of iodide organification,

iodothyronine synthesis, thyroxine secretion,

pseudopod formation, and colloid endocytosis.

Thyrotropin also rapidly

stimulates energy production, as reflected in glucose uptake,

lactate

formation, mitochondrial oxidative metabolism (which accounts for 80%
of thyroid ATP production) and incorporation of glucose carbon into
lipid.

Nearly all of these effects are enhanced by phosphodiesterase

28
inhibitors and mimicked by dbcAMP*.

32

These early effects of thyro¬

tropin are all unaffected by the presence of inhibitors of protein or
RNA synthesis.^
TSH also evokes less rapid responses in the thyroid cell.
Active iodide transport, which at first is in fact inhibited by TSH,
is ultimately stimulated after a delay of 2 to 4 hours, and the stim¬
ulation is prevented by cycloheximide or actinomycin D.

Both the

lag period and the effect of inhibitors suggest that activation of the
iodide pump requires synthesis of new protein from newly transcribed
RNA.

9^

Thyrotropin also stimulates the incorporation of inorganic

90
phosphate into membrane phospholipid.'
of enhanced RNA ’±z- and protein

While biochemical evidence

synthesis is present within one hour,

interpretation of these findings is complicated by nonspecific uptake
of labelled precursors and endocytosis of thyroglobulin.

Nevertheless,

microscopic evidence of synthetic activity appears after 2 to 4 hours
of stimulation, and includes an increase in the number of clustered
membrane-free ribosomes, dilation of the cisternae of the endoplasmic
reticulum, greater development of the Golgi apparatus, and augmented
cell height.

Some traces of enhanced synthetic activity,

such as the

synthesis of lysosomal enzymes, persist after the rapid secretory
responses are no longer evident.

32

Kerkof and Tata proposed in 1969 that the slower biosynthetic
responses to TSH are not mediated by cAMP, while the rapid effects

*0ne exception:
low concentrations of TSH inhibit glucose
oxidation through the pentose phosphate pathway, though higher con¬
centrations cause stimulation; the inhibition, but not the stimulation,
appears to involve cAMP.46
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are.^

However, dbcAMP does reproduce the enhancement by TSH of iodide

transport, which requires both transcription and translation;

93 197
5
it

mimics the stimulation of nuclear RNA polymerase in pig thyroid slices,

2

and it reproduces the effect of TSH on leucine incorporation into pro¬
tein.

The stimulation by TSH of protein synthesis in beef thyroid

cells in vitro has in fact been shown to consist of two phases:
'immediate'

(a) an

stimulation seen within 30 minutes of TSH administration and

disappearing promptly when TSH is removed, which is not affected by in¬
hibitors of transcription, and (b) a 'delayed' phase occurring after one
to two hours and persisting after thyrotropin is withdrawn, which is
completely dependent on RNA synthesis.

Both effects are reproduced in

all respects by dbcAMP.168
Chronic stimulation of the thyroid with daily injections of thyro¬
tropin leads to cell proliferation to provide for continued production
of thyroid hormone.

Cell mass and number increase.

DNA content per

cell is elevated,

reflected microscopically in an increased number of

polyploid cells.

The follicle lumen decreases markedly in size despite

an augmented thyroglobulin synthesis, reflecting an increased thyroglobulin
turnover rate.

This, together with an increase in cell size, gives an

elevated cell:colloid ratio, a useful index of stimulation.

The vascuT O

lar supply of the gland is increased to support this activity.

.

EXPERIMENTAL

EXPERIMENTAL

Purpose of This Study
While many of the effects of thyrotropin on thyroid economy have
been characterized, the mechanisms by which they are brought about remain
unclear.

This is especially true for the growth-promoting aspects of

TSH stimulation, which include synthesis of thyroglobulin as well as
of cellular constituent proteins, nucleic acids, and phospholipids.

A

better knowledge of this regulation could have potential significance for
our understanding of nontoxic goiter and thyroid neoplasia, both of which
are common.

As polyamines are associated with conditions of growth in

other organs, and as they can stimulate RNA and protein synthesis in
cell-free systems,

it is possible that polyamines are involved in the

regulation of growth in the thyroid as well.
In vivo work on thyroid ODC has demonstrated stimulation of the
enzyme by TSH.

One laboratory has shown stimulation with dbcAMP and

aminophyl1ine,

although this has not been confirmed.

Such studies

are complicated by pharmacologic effects of nucleotides on the pituitary^
and blood vessels.

1 97

In the present study, we have investigated in vitro the role of
cAMP in the stimulation of ODC activity by TSH.

We have further explored

a possible function for this stimulation by studying the temporal rela¬
tionship between the elevated ODC activity, raised polyamine levels, and
enhanced

RNA

accumulation after TSH administration in vitro.
30

L

.
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Methods and Materials
Male Sprague-Dawley rats weighing 200 g were obtained from Charles
River Laboratories.

The thyroid glands were removed and randomized with

4 to 12 lobes placed in each beaker.
Krebs bicarbonate buffer (KRB)

The lobes were preincubated in 5 ml

for 15 minutes and then incubated for 1-7

hours in KRB with various agents, in a Dubnoff metabolic shaker at 37 C,
in a 95% 02/5% CO2 atmosphere.

Quantitive bacterial determinations of

the media were made at intervals up to 7 hours, and no significant con¬
tamination occurred.

Following incubation, thyroids were homogenized in

appropriate media (specified below) with a mechanically drive Teflon pestle
in a Potter-Elvehjem tube.

Homogenates were then centrifuged at 4 C, and

the supernatants assayed for ODC activity or polyamines.

For ODC assay,

4 lobes representing 40-60 mg of tissue were homogenized in 1.4 ml of
buffer composed of 0.25 M sucrose, 0.5 mM EDTA and 10 mM 2-mercaptoethanol;
and centrifuged at 100,000 x g for 30 minutes.
ations,

For polyamine determin¬

8-10 lobes were homogenized in .4 ml of .4 N perchloric acid and

centrifuged at 1,000 x g for 10 minutes.

Enzyme Assay
ODC activity was assayed by measuring ^C02 produced from DL- l-l^c
-ornithine as described by Russell and Snyder
et al.

20

as follows:

158

and modified by Chen,

the assay mixture contained 0.6 mM DL-orithine,

0.1 mM pyridoxal-5-phosphate, 25 mM Tris-HCl buffer (pH 7.88 at 37 C),
13 nmoles mercaptoethanol, and 100 yl of supernatant representing .06-0.2
mg protein, in a final volume of 215 yl.

Within this range of protein

concentration, ODC activity was linear with thyroid protein concentration.

32
Ornithine was prepared for assay by acidification to 0.1 N HC1,
heating on a rotary evaporator under vacuum to 54 C for 30 minutes and
redilution to 0.01 N HC1, to remove a volatile contaminant which other¬
wise gave high assay blanks.

Cold ornithine was added with dilution,

prior to assay, to give a final specific activity of 5.8 mCi/mole.
Decarboxylation was carried out in #2057 Falcon tubes, with
a polyethylene well containing 0.2 ml of 1:2 monoethalolamine:ethylene
glycol monoethyl ether suspended from the stopper by a needle.

Decar¬

boxylation was linear with time for up to 2 hours of incubation;
assays in the present study were incubated for 90 minutes at 37 C in a
shaker bath.

The reaction was stopped by injection of 0.4 ml 2 N

citric acid through the needle.

After agitation for an additional 60

minutes at 37 C, each well was removed, placed in 15 ml Aquasol

(New

England Nuclear) and counted on a Packard Tri-carb or a Searle Mark II
scintillation counter.
The amount of ^C02 released from substrate in tubes with no
enzyme was subtracted from the value for all other samples.

Picomoles

of ^^C02 released from the L-isomer only was calculated.

Enzyme

activity was expressed as picomoles ^^C02 released per milligram of
protein per hour of assay incubation.

Protein determination was by

the Folin-Lowry method^^ using a least-squares calculation for a BSA
standard curve.
ODC activity was measured between pH 6.6 and 9.9 and found to
be maximal from 7.7 to 8.1.

Maximal ODC activity was seen at 48 C.

Kinetic studies reproducibly demonstrated a Km for ornithine of 0.12
mM, closely comparable to the ODC observed in other mamalian systems

•

.
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though at variance with the only other Km reported for the thyroid
enzyme.

Our samples was assayed at pH 7.88,

37 C and .6 mM DL-

ornithine.

Polyamine Assay
Tissue levels of putrescine, spermidine, and spermine were
determined by dansylation according to the method of Dion and Herbst.
PCA spernatant

29

(0.2 ml) was added to <$„4 ml of dansyl chloride (30 mg/ml

acetone) and 18.5 mg anhydrous Na^CO^.

After 16 hours in the dark at

room temperature, 0.1 ml of proline (100 mg/ml ^0) was added for 30
minutes to convert excess dansyl chloride to dansyl proline.

Dansyl

derivatives were extracted into 0.5 ml benzene, and 10 yl of the
benzene layer was spotted onto 250 ym Silica gel TLC plates which
had been heated to 100° for one hour prior to spotting.

Standard

samples of all three amines were spotted on each plate as well.
Plates were run twice with 2:3 ethylacetate/cyclohexane (v/v) in the
dark, and sprayed immediately with 1:4 triethanolamine/ethylene glycol
(v/v).

Plates were dried in a dark vacuum for 16 hours and allowed

to equilibrate to atmospheric pressure for one hour before scanning
on a Turner 111 fluorometer with TLC scanner.

Blanks were scanned

between the putrescine and spermidine spots and were sub tracted from
values for each sample.

The area under each peak (determined by

weighing the peak) was proportional to the amount of dansyl amine at
that spot between 0-5 nmoles for putrescine and 0-20 nmoles for sper¬
midine and spermine.

The assay had a reproducibility of ±11.7% for

putrescine, 14.2% for spermidine, and 13.7% for spermine.

Tissue

'
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levels were expressed as nmoles/g of tissue weighed after incubation.
Medium was lyophilized, solubilized in 0.4N per perchloric acid, and
assayed as above.

RNA Synthesis
For those experiments in which RNA synthesis was measured,
thyroids were incubated as above with ^H-uridine (10 yCi/ml) added to
the incubation medium.

The pellet remaining after PCA centrifugation

was washed 3 times in 5% tricholoroacetic acid and resuspended in 0.2
i

ml 1 N NaOH; 20 yl aliquots were counted in Aquasol.

3

. .
H-undme

incorporation into RNA was expressed as cpm per g of tissue.

Materials
TSH was kindly supplied by the National Institutes of Health
(NIH-THS-B7).

3-Isobutyl-l-methyl xanthine was purchased from the

Aldrich Chemical Company.

Dibutyryl 3'5'

cyclic monophosphoric acid,

actinomycin D, puromycin, putrescine, spermidine, spermine, dansyl
choloride, and ipronizaid phosphate were purchased from Sigma Chemicals
Uridine-6-H^ (24.2 Ci/nmole,

lot #908-053) and DL- 1-^C - ornithine

monohydrochloride (lot #822-176) were obtained from New England Nuclear

Results
Stimulation of Thyroid ODC In Vitro
Incubation of rat thyroid lobes with 50 mU/ml of TSH resulted
in a 3 to 5-fold stimulation of ODC activity at 5 hours

(p< .001).

The addition of 0.5 mM 3-isobutyl-l-methyl xanthine (MIX), a potent
phosphodiesterase inhibitor, more than doubled this stimulation, with

'

.
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peak ODC activity occurring usually at 5 hours, and occasionally at
6 hours (Figure 2).

Incubation with MIX alone stimulated ODC activ¬

ity, with stimulation by 0.5 mM MIX not significantly different from
stimulation by 50 mU/ml of TSH at 5 hours of incubation.
tions with MIX were at a concentration of 0.5 mM.
control activity with time (Figure 2)

All incuba¬

The small rise in

is unexplained, but a similar

rise was observed by Cohen, et al., in chick oviducts in vitro.

26

Pilot experiments with calf thyroid slices showed the ODC
activity in this tissue to rise only two to three-fold when incubated
with TSH and MIX.

Further studies with this species were not pursued.

The stimulation of rat thyroid ODC activity by TSH was doserelated:

5 mU/ml of TSH significantly elevated ODC activity over

control, and maximal stimulation was seen with 25 mU/ml

(Figure 3).

All subsequent incubations with TSH were done at a concentration of
50 mU/ml.
Incubation of thyroids with dibutyryl cyclic AMP (dbcAMP) re¬
sulted in dose-related stimulation of ODC activity up to a concentra¬
tion of 2 mM.

There was no stimulation over control at 5 mM dbcAMP,

as confirmed by several repetitions

(Figure 4).

The stimulation of

ODC activity by 1 mM dbcAMP was not enhanced by the addition of MIX.

Effects of Inhibitors of RNA and Protein
Synthesis on Thyroid ODC Activity
The addition to 0.2 mM puromycin or 10 yg/ml actinomycin D to
the preincubation and incubation medium inhibited stimulation of ODC
activity in response to TSH and MIX (Figure 5).

Puromycin completely

prevented the rise in ODC activity in either stimulated or control

■

.

'
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thyroids.

A concentration of 1% ethanol was required to solubilize the

actomycin D; this concentration was found to eliminate the ODC activity
in the incubated control and to attenuate the ODC response to TSH and
MIX.

Thus while the data show inhibition of ODC activity by actinomycin

D, it is impossible to distinguish complete from incomplete inhibition.

Stimulation of Thyroid Amine
Levels in vitro
Thyroid lobes contained basal levels of about 300 nmoles/g of
spermidine and spermine and one-tenth as much putrescine.

Tissue

levels of all three amines did not rise before the fifth hour of in¬
cubation with TSH and MIX.

At six hours, a three-fold increase in

tissue putrescine levels was observed (p <.05), together with marked
leakage of putrescine into the medium, when thyroids were incubated
in TSH

and MIX (Figure 6).

icantly elevated at 6 hours.

Spermidine and spermine were not signif¬
Both control and stimulated samples in

this experiment were incubated with 5 mM iproniazid, an amine oxidase
inhibitor, to prevent polyamine degradation.

Time Course of Stimulation of ODC Activity,
Putrescine Content, and RNA Synthesis
Figure 7 illustrates the time course for ODC activity, putres¬
cine levels, and ^H-uridine incorporation into RNA in a representative
incubation with TSH and MIX.

ODC activity rose at 4 hours, peaked at

5 hours, and declined thereafter.

Although these samples were incubated

without iproniazid, putrescine levels were significantly elevated over
controls at 6 hours, following the ODC peak (p<.05).

Spermidine and

spermine levels were again not significantly elevated during this time
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period.

Putrescine leakage into the medium closely paralleled tissue

levels.

RNA synthesis as measured by incorporation of tritiated uri¬

dine into acid-insoluble material, rose significantly at the seventh
hour.

Discussion
This is the first report of stimulation of thyroid ODC in vitro.
Our results match the earlier in vivo observations that a single in¬
jection of TSH in rats yields peak activity of thyroid ODC 4 to 6
hours later.H6,150,202

The 3 to 5-fold rise in vitro is comparable

to the degree of stimulation observed in vivo in hypophysectomized
rats, but significantly less than that found with intact rats.

202

Role of cAMP in ODC stimulation
Dibutyryl cyclic AMP has been shown to stimulate ODC activity
in the adrenals of hypophysectomized rats,149 cultured mammary tissue,
and when given with aminophylline in thyroids of normal rats.

13"

202

Enzyme activity in livers of intact rats was stimulated by dbcAMP,^’^
but not consistently in livers of hypophysectomized rats.

As dbcAMP

is known to cause release of pituitary hormones'^ and to alter blood
flow,

in vivo studies must be interpreted carefully.

Further,

there are systems in which ODC stimulation occurs without changes in
tissue cAMP levels.
tissues,
plants.

2
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Insulin, which lowers cAMP levels in target

stimulates ODC activity in liver^’l^ and in mammary exThus in some systems induction of ODC activity appears to

involve a mechanism independent of cAMP.
Sutherland^! has suggested four criteria by which to judge a

'
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claim that a given hormone produces a given effect through the media¬
tion of cAMP:
1.

the hormone should stimulate adenylate cyclase in broken

cell preparations; this effect should be specific for that hormone;
2.

the hormone should elevate cAMP levels in intact cells;

this again should be a specific effect, detectable at the smallest
dose of hormone producing the physiological response and occurring as
early as or earlier than that response;
3.

the response to the hormone should be potentiated by

phosphodiesterase inhibitors;
4.

exogenous cAMP or one of its soluble derivatives should re¬

produce the response.
TSH specifically

activates

adenylate cyclase in thyroid plasma

7 Q

membrane

preparations.

°

Thyrotropin also raises intracellular cAMP

levels, beginning at 0.25-0.3 mU/ml in the beef thyroid;

46 19?
5
“ the

first siginficant effect on ODC activity in the rat thyroid is seen at
5 mU/ml

(although this is not strictly comparable because of species

variation, differing TSH preparations, and probably other experimental
differences as well).

The effect of thyroid ODC activity is specific

for TSH^O- and is markedly enhanced by the addition of MIX.

Finally,

the ODC response is reproduced in a dose-related manner by exogenous
dbcAMP.

The ineffectiveness of 5 mM dbcAMP is not surprising,

for

Sutherland remarks that dose-responses to exogenous cAMP are character¬
istically "bell-shaped over a relatively narrow range," probably be¬
cause of toxic effects of the nucleotide at supraphysiologic concen¬
trations;'*'^ such behavior has been seen before in the thryoid.^

Thus
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the stimulation of ODC activity appears to satisfy all of Sutherland's
criteria.
ODC activity continues to rise at TSH concentrations signif¬
icantly above those required for most physiological responses.

This,

70

however,

is also the case for cAMP in most species,

levels in the mouse thyroid,
TSH.

with peak cAMP

for example, occurring at 30 mU/ml of

The stimulation of ODC activity might then be a purpose for

such previously unexplained peak cAMP levels.

A similar situation

exists in the adrenal, where ODC activity and cAMP accumulation are
still stimulated at ACTH levels far beyond those needed for maximal
■ ,
•
149
steroidogenesis.
The elevation of putrescine content with ODC activity implies
that the increase in ODC activity is physiologic rather than an assay
artifact.

Polyamine levels reported here are comparable to those found

in other rat organs^ >76 if a correction is made for the extracellular
thyroglobulin content of the thyroid.

The accumulation of putrescine

alone during the 7 hour incubation in the present study is similar to
the finding in regenerating rat liver that putrescine levels rise by
2 to 3-fold beginning 4 hours after partial hepatectomy, while spermidine rises by much less and not until 8 hours.

7 (S

Matsuzaki and Suzuki

reported elevation of putrescine and spermidine levels in the thyroid
beginning on the second day of goitrogen treatment.
The degree of putrescine leakage into the medium was unexpected.
In the presence of 5 mM iproniazid it is unlikely that this represents
putrescine produced by the breakdown of oxidized spermidine or spermine.

Putrescine is less well bound to cellular constituents than

•
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are spermidine and spermine,

?4

and this might explain the elevation of

putrescine in the medium in the absence of any change in spermidine or
spermine content of the medium.
We have found that ODC activity and putrescine levels rise prior
to an increase in

H-uridine incorporation into RNA.

Stimulation of

^H-uridine incorporation has been observed in vitro after one to four
hours of incubation with TSH by several
tigators.
hours;

7 17 1 07

though not all
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inves¬

In none of these studies was incubation carried out for seven

it is possible that our methods were too insensitive to detect

a small earlier change in uridine uptake into RNA.
Studies using metabolic inhibitors indicate that stimulation
of ODC activity requires new synthesis of RNA. 1*^,202

It also has been

proposed that polyamines participate in the regulation of RNA synthesis,
which was also suggested by our findings.

This is compatible with a

model whereby a small early increase in RNA production might lead to
a polyamine accumulation which would be followed by greater augmenta¬
tion of nucleic acid synthesis.
Regulation of ODC activity in the thyroid seems to depend on
synthesis of new protein and RNA^0,202 and the effects of inhibitors
are confirmed by the present data.

However, whether there is actually

an induction of protein or a change in the activity of ODC is not known.
In preliminary experiments not reported here, an antibody to partially
purified hepatic ODC^^ inactivated about 90% of the ODC activity in
TSH-stimulated thyroid supernatants.

Further, radio-iodinated anti¬

body appeared to precipitate protein as it inactivated ODC, suggesting
that TSH stimulation of ODC activity did in fact represent induced

41
synthesis of enzyme protein.
TSH has several immediate effects on the thyroid such as the
stimulation of adenylate cyclase and the release of thyroid hormones.

32 200
’

Continued TSH stimulation results in additional effects

including enhanced uptake of iodide and thyroglobulin synthesis.

93

’

1 34

These delayed effects appear to differ from the immediate ones in that
they require synthesis of protein and RNA.

Polyamines might play a

role in modulating this latter phase of TSH stimulation in the thyroid

S-Adenosylmethionine (SAM)

Spermidine

Spermine

FIGURE 1:
Polyanine Biosynthesis

ODC ACTIVITY (pmoles 14C02/mg protcin/hr incubation)

FIGURE 2

The time course of ODC activity in thyroids incubated with
50 mU/ml TSH and 0.5 mM MIX (•-) ard in controls (‘-•
A typical experiment is shown.
Each point represents the
mean * SEM of 5 determinations.

ODC ACTIVITY

(pmoles 14C02/mg protein/hr incubation)

FIGURE 3

[TSH] (mU/ml)

Effect of varying concentrations of TSH on thyroid ODC
activity ft 5 hours of incubation.
Each point represents
the mean - 5EM of 3 determinations.

FIGURE 4

CDb cAMP] (mM)

Effect, ot varying concentrations of dbcAMP on thyroid ODC
activity at 5 hours of incubation.
Each point represents
the mean ± SEM of 3 determinations.
Bar graph represents
stimulation with 50 mU/ml TSH.

(pmoles ’4C02/™g protein/hr incubation)

FIGURE 5
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Xanthine

Control

TSH +
Methyl
Xanthine

Actmomycin D
+ TSH
+ Methyl
Xanthine

Upper figure:
Effect of 0.2 niM puromycin on the stimulation
of thyroid ODC activity hi vitro at 5 hours of incubation as
compared with stimulated thyroids without inhibitor and con¬
trols .
Lower figure:
Effect of 10 yg/ml actinomvcin D on the stim¬
ulation of ODC activity as compared with stimulated thyroids
and controls.
Each value represents the mean - SEM of 3 determinations.
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The time course of ODC activity, putrescine levels, and RNA
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